表紙：早漏症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

市場調査レポート

商品コード

1182395

早漏症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

Premature Ejaculation Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

出版日: 2022年11月30日 | 発行: Acute Market Reports

| ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 707,130円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 1,021,410円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,414,260円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

早漏症治療薬の市場規模は、2021年の22億5,250万米ドルから、予測期間中は8.8％のCAGRで推移し、2030年には47億8,790万米ドルの規模に成長すると予測されています。

北米では、医療インフラが整備されていること、早漏症の有病率が上昇していることが市場成長の要因となっています。また、アジア太平洋地域では、成熟したジェネリック医薬品市場の存在と早漏症の認知度向上が市場成長を促進しています。薬剤クラス別では、その薬力学的特性により、選択的セロトニン再取り込み阻害薬 (SSRI) が第一選択薬となっています。

当レポートでは、世界の早漏症治療薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。

List of Tables

TABLE 1 Global Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 2 Global Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 3 Global Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 4 Global Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 5 Global Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 6 Global Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 7 North America Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 8 North America Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 9 North America Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 10 North America Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 11 North America Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 12 North America Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 13 U.S. Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 14 U.S. Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 15 U.S. Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 16 U.S. Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 17 U.S. Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 18 U.S. Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 19 Canada Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 20 Canada Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 21 Canada Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 22 Canada Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 23 Canada Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 24 Canada Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 25 Rest of North America Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 26 Rest of North America Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 27 Rest of North America Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 28 Rest of North America Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 29 Rest of North America Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 30 Rest of North America Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 31 UK and European Union Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 32 UK and European Union Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 33 UK and European Union Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 34 UK and European Union Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 35 UK and European Union Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 36 UK and European Union Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 37 UK Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 38 UK Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 39 UK Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 40 UK Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 41 UK Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 42 UK Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 43 Germany Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 44 Germany Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 45 Germany Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 46 Germany Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 47 Germany Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 48 Germany Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 49 Spain Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 50 Spain Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 51 Spain Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 52 Spain Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 53 Spain Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 54 Spain Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 55 Italy Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 56 Italy Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 57 Italy Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 58 Italy Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 59 Italy Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 60 Italy Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 61 France Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 62 France Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 63 France Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 64 France Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 65 France Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 66 France Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 67 Rest of Europe Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 68 Rest of Europe Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 69 Rest of Europe Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 70 Rest of Europe Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 71 Rest of Europe Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 72 Rest of Europe Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 73 Asia Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 74 Asia Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 75 Asia Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 76 Asia Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 77 Asia Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 78 Asia Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 79 China Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 80 China Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 81 China Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 82 China Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 83 China Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 84 China Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 85 Japan Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 86 Japan Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 87 Japan Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 88 Japan Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 89 Japan Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 90 Japan Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 91 India Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 92 India Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 93 India Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 94 India Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 95 India Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 96 India Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 97 Australia Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 98 Australia Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 99 Australia Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 100 Australia Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 101 Australia Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 102 Australia Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 103 South Korea Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 104 South Korea Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 105 South Korea Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 106 South Korea Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 107 South Korea Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 108 South Korea Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 109 Latin America Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 110 Latin America Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 111 Latin America Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 112 Latin America Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 113 Latin America Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 114 Latin America Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 115 Brazil Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 116 Brazil Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 117 Brazil Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 118 Brazil Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 119 Brazil Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 120 Brazil Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 121 Mexico Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 122 Mexico Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 123 Mexico Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 124 Mexico Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 125 Mexico Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 126 Mexico Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 127 Rest of Latin America Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 128 Rest of Latin America Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 129 Rest of Latin America Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 130 Rest of Latin America Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 131 Rest of Latin America Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 132 Rest of Latin America Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 133 Middle East and Africa Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 134 Middle East and Africa Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 135 Middle East and Africa Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 136 Middle East and Africa Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 137 Middle East and Africa Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 138 Middle East and Africa Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 139 GCC Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 140 GCC Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 141 GCC Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 142 GCC Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 143 GCC Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 144 GCC Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 145 Africa Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 146 Africa Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 147 Africa Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 148 Africa Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 149 Africa Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 150 Africa Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)
TABLE 151 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Drug Class, 2020-2030, USD (Million)
TABLE 152 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Selective Serotonin Reuptake Inhibitor, 2020-2030, USD (Million)
TABLE 153 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Tricyclic Antidepressant, 2020-2030, USD (Million)
TABLE 154 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Topical Anesthetic Agent, 2020-2030, USD (Million)
TABLE 155 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Phosphodiesterase Type 5 Inhibitors, 2020-2030, USD (Million)
TABLE 156 Rest of Middle East and Africa Premature Ejaculation Treatment Market By Route of Administration, 2020-2030, USD (Million)

List of Figures

FIG. 1 Global Premature Ejaculation Treatment Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Premature Ejaculation Treatment Market: Quality Assurance
FIG. 5 Global Premature Ejaculation Treatment Market, By Drug Class, 2021
FIG. 6 Global Premature Ejaculation Treatment Market, By Route of Administration, 2021
FIG. 7 Global Premature Ejaculation Treatment Market, By Geography, 2021
FIG. 8 Market Geographical Opportunity Matrix - Global Premature Ejaculation Treatment Market, 2021
FIG. 9 Market Positioning of Key Premature Ejaculation Treatment Market Players, 2021
FIG. 10 Global Premature Ejaculation Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
FIG. 11 Global Premature Ejaculation Treatment Market, By Drug Class, 2021 Vs 2030, %
FIG. 12 Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 Vs 2030, %
FIG. 13 U.S. Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 14 Canada Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 15 Rest of North America Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 16 UK Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 17 Germany Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 18 Spain Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 19 Italy Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 20 France Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 21 Rest of Europe Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 22 China Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 23 Japan Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 24 India Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 25 Australia Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 26 South Korea Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 27 Rest of Asia Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 28 Brazil Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 29 Mexico Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 30 Rest of Latin America Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 31 GCC Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 32 Africa Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030
FIG. 33 Rest of Middle East and Africa Premature Ejaculation Treatment Market (US$ Million), 2020 - 2030

Product Code: 138271-08-22

Industry Outlook

The premature ejaculation treatment market is set to reach US$ 4,787.9 Mn by 2030 from US$ 2,252.5 Mn in 2021 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.8% during the forecast period from 2022 to 2030. According to the research survey conducted by the International Journal of Impotence Research (IJIR), 30% adult men throughout the globe suffer with premature ejaculation. The prevalence rate of premature ejaculation varies across geographical and socio-cultural population. Premature ejaculation has been understood to cause a negative impact on the sexual satisfaction in men and their sexual partners.

People suffering with premature ejaculation are less likely to seek medical help, thus making it of utmost importance to raise awareness and acceptance of this disorder in patients and physicians. Existence of developed healthcare infrastructure and rising prevalence of premature ejaculation disorder drive the market growth in North America. Presence of matured generic drug market and increasing awareness of premature ejaculation propel the market growth in Asia Pacific.

Impressive pharmacodynamic properties exerted by SSRI's make it drug of first choice for premature ejaculation treatment

Selective serotonin reuptake inhibitors are prescribed as the first line drug therapy for treatment of premature ejaculation. The mechanism of action involved is delayed ejaculation due to limited reabsorption of serotonin at the presynaptic neuron cells and increasing the serotonin levels at the postsynaptic receptors. The drugs prescribed as SSRI's are sertraline, paroxetine, fluoxetine and citalopram. Topical anesthetic agents are set to project impressive growth during the forecast period 2022 to 2030. Currently Fortacin™ a eutectic mixture of Lidocaine and Prilocaine is being used as a topical aerosol formulation to decrease sensitivity of glans penis and increase the intravaginal ejaculation latency time. The topical anesthetic agents have better patient compliance and excellent sexual satisfaction in patients suffering with premature ejaculation.

Faster onset on action and low price makes oral route of administration popular among patients suffering with acute premature ejaculation

Prescribed drugs such as SSRI's, tricyclic antidepressant, Phosphodiesterase type 5 inhibitors and beta-adrenergic blockers are taken by oral route of administration. Quick response time and availability at low price increases the popularity of oral route among patients suffering with acute premature ejaculation. Topical route is to register magnificent growth during the forecast period 2022 to 2030 due to better patient compliance and excellent climax control by delaying the intravaginal ejaculation.

Rise in psychotropic drug use and lack of constructive attitude towards sex determines Asia Pacific market growth

In the present scenario North America holds the largest regional market in premature ejaculation treatment market with 41.5% share. Rising incidence of relationship stress, depression and anxiety in younger population and increasing number of people suffering with illicit drug abuse are responsible for premature ejaculation issues in North America. Domicile of market leaders such as GlaxoSmithkline Plc and Teva Pharmaceutical Industries Ltd., and adherence to effective treatment guidelines drives the premature ejaculation treatment market in Europe. Asia Pacific serves as a lucrative market for premature ejaculation treatment. The factors responsible for the market growth are rise in psychotropic drug use and lack of constructive attitude towards sex. Latin America and Middle East and Africa will project moderate growth during the forecast period 2018 to 2026 on account of developing healthcare infrastructure and rising public health awareness regarding premature ejaculation.

The premature ejaculation market comprises of branded and generic drugs which are prescribed according to the disease prognosis. Inorganic and organic market growth strategies are being employed by market leaders to generate revenue in premature ejaculation treatment market. Quantitative analysis is a very useful tool for mapping the drivers, restraints and opportunities prevalent in the premature ejaculation treatment market. Diverse product portfolio gives a better understanding of the competition prevalent in the market. The pharmaceutical companies commanding the premature ejaculation treatment market are Absorption Pharmaceuticals, AstraZeneca, Allergan Plc, Bayer AG, Eli Lilly & Company, GlaxoSmithkline Plc, Innovus Pharmaceuticals, Merck & Co., Inc., Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Premature Ejaculation Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Premature Ejaculation Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

Selective Serotonin Reuptake Inhibitor
- Paroxetine
- Sertraline
- Citalopram
- Fluoxetine

Tricyclic Antidepressant
- Clomipramine

Topical Anesthetic Agent
- Lidocaine/Prilocaine
- Benzocaine

Phosphodiesterase Type 5 Inhibitors
- Sildenafil
- Vardenafil

Others (Beta-adrenergic Blockers, Analgesic Opioids)

Route of Administration

Oral Route
Topical Route

Region Segment (2020-2030; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation
Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Premature Ejaculation Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Premature Ejaculation Treatment market?

Which is the largest regional market for Premature Ejaculation Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Premature Ejaculation Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Premature Ejaculation Treatment market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Premature Ejaculation Treatment Market
2.2. Global Premature Ejaculation Treatment Market, By Drug Class, 2021 (US$ Million)
2.3. Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 (US$ Million)
2.4. Global Premature Ejaculation Treatment Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021

3. Premature Ejaculation Treatment Market: Competitive Analysis

3.1. Market Positioning of Key Premature Ejaculation Treatment Market Vendors
3.2. Strategies Adopted by Premature Ejaculation Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Premature Ejaculation Treatment Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Premature Ejaculation Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
- 5.3.1. Selective Serotonin Reuptake Inhibitor
  - 5.3.1.1. Paroxetine
  - 5.3.1.2. Sertraline
  - 5.3.1.3. Citalopram
  - 5.3.1.4. Fluoxetine
- 5.3.2. Tricyclic Antidepressant
  - 5.3.2.1. Clomipramine
- 5.3.3. Topical Anesthetic Agent
  - 5.3.3.1. Lidocaine/Prilocaine
  - 5.3.3.2. Benzocaine
- 5.3.4. Phosphodiesterase Type 5 Inhibitors
  - 5.3.4.1. Sildenafil
  - 5.3.4.2. Vardenafil
- 5.3.5. Others (Beta-adrenergic Blockers, Analgesic Opioids)

6. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
- 6.3.1. Oral Route
- 6.3.2. Topical Route

7. North America Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

7.1. Market Overview
7.2. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
7.3. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
7.4.Premature Ejaculation Treatment Market: By Region, 2020-2030, USD (Million)
- 7.4.1.North America
  - 7.4.1.1. U.S.
    - 7.4.1.1.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 7.4.1.1.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 7.4.1.2. Canada
    - 7.4.1.2.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 7.4.1.2.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 7.4.1.3. Rest of North America
    - 7.4.1.3.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 7.4.1.3.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

8. UK and European Union Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

8.1. Market Overview
8.2. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
8.3. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
8.4.Premature Ejaculation Treatment Market: By Region, 2020-2030, USD (Million)
- 8.4.1.UK and European Union
  - 8.4.1.1. UK
    - 8.4.1.1.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.1.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 8.4.1.2. Germany
    - 8.4.1.2.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.2.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 8.4.1.3. Spain
    - 8.4.1.3.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.3.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 8.4.1.4. Italy
    - 8.4.1.4.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.4.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 8.4.1.5. France
    - 8.4.1.5.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.5.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 8.4.1.6. Rest of Europe
    - 8.4.1.6.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 8.4.1.6.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

9. Asia Pacific Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

9.1. Market Overview
9.2. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
9.3. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
9.4.Premature Ejaculation Treatment Market: By Region, 2020-2030, USD (Million)
- 9.4.1.Asia Pacific
  - 9.4.1.1. China
    - 9.4.1.1.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.1.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 9.4.1.2. Japan
    - 9.4.1.2.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.2.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 9.4.1.3. India
    - 9.4.1.3.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.3.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 9.4.1.4. Australia
    - 9.4.1.4.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.4.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 9.4.1.5. South Korea
    - 9.4.1.5.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.5.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 9.4.1.6. Rest of Asia Pacific
    - 9.4.1.6.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 9.4.1.6.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

10. Latin America Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

10.1. Market Overview
10.2. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
10.3. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
10.4.Premature Ejaculation Treatment Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Latin America
  - 10.4.1.1. Brazil
    - 10.4.1.1.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 10.4.1.1.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 10.4.1.2. Mexico
    - 10.4.1.2.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 10.4.1.2.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 10.4.1.3. Rest of Latin America
    - 10.4.1.3.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 10.4.1.3.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

11. Middle East and Africa Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

11.1. Market Overview
11.2. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
11.3. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
11.4.Premature Ejaculation Treatment Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Middle East and Africa
  - 11.4.1.1. GCC
    - 11.4.1.1.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 11.4.1.1.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 11.4.1.2. Africa
    - 11.4.1.2.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 11.4.1.2.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)
  - 11.4.1.3. Rest of Middle East and Africa
    - 11.4.1.3.1. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)
    - 11.4.1.3.1. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

12. Company Profile

12.1. Absorption Pharmaceuticals
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
12.2. AstraZeneca
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
12.3. Allergan, Plc
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
12.4. Bayer AG
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
12.5. Eli Lilly & Company
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
12.6. GlaxoSmithkline, Plc
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
12.7. Innovus Pharmaceutical
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
12.8. Merck & Co., Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
12.9. Pfizer, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
12.10. Teva Pharmaceutical Industries Ltd.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives

早漏症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

Premature Ejaculation Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 早漏症治療薬市場：競合分析

第4章 早漏症治療薬市場：マクロ分析・市場力学

第5章 早漏症治療薬市場：薬剤クラス別

第6章 早漏症治療薬市場：投与経路別

第7章 北米の早漏症治療薬市場

第8章 英国およびEUの早漏症治療薬市場

第9章 アジア太平洋の早漏症治療薬市場

第10章 ラテンアメリカの早漏症治療薬市場

第11章 中東およびアフリカの早漏症治療薬市場

第12章 企業プロファイル

List of Tables

List of Figures

Industry Outlook

Impressive pharmacodynamic properties exerted by SSRI's make it drug of first choice for premature ejaculation treatment

Faster onset on action and low price makes oral route of administration popular among patients suffering with acute premature ejaculation

Rise in psychotropic drug use and lack of constructive attitude towards sex determines Asia Pacific market growth

Historical & Forecast Period

Research Methodology

Geographical revenues generate by countries considered in the report:

Market Segmentation

Drug Class

Route of Administration

Region Segment (2020-2030; US$ Million)

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Key questions answered in this report:

Table of Contents

1. Preface

2. Executive Summary

3. Premature Ejaculation Treatment Market: Competitive Analysis

4. Premature Ejaculation Treatment Market: Macro Analysis & Market Dynamics

5. Premature Ejaculation Treatment Market: By Drug Class, 2020-2030, USD (Million)

6. Premature Ejaculation Treatment Market: By Route of Administration, 2020-2030, USD (Million)

7. North America Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

8. UK and European Union Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

9. Asia Pacific Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

10. Latin America Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

11. Middle East and Africa Premature Ejaculation Treatment Market, 2020-2030, USD (Million)

12. Company Profile

第1章序文

第2章エグゼクティブサマリー

第3章早漏症治療薬市場：競合分析

第4章早漏症治療薬市場：マクロ分析・市場力学

第5章早漏症治療薬市場：薬剤クラス別

第6章早漏症治療薬市場：投与経路別

第7章北米の早漏症治療薬市場

第8章英国およびEUの早漏症治療薬市場

第9章アジア太平洋の早漏症治療薬市場

第10章ラテンアメリカの早漏症治療薬市場

第11章中東およびアフリカの早漏症治療薬市場

第12章企業プロファイル